BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 30381997)

  • 1. Repetitive Transcranial Magnetic Stimulation with Resting-State Network Targeting for Treatment-Resistant Depression in Traumatic Brain Injury: A Randomized, Controlled, Double-Blinded Pilot Study.
    Siddiqi SH; Trapp NT; Hacker CD; Laumann TO; Kandala S; Hong X; Trillo L; Shahim P; Leuthardt EC; Carter AR; Brody DL
    J Neurotrauma; 2019 Apr; 36(8):1361-1374. PubMed ID: 30381997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Individualized precision targeting of dorsal attention and default mode networks with rTMS in traumatic brain injury-associated depression.
    Siddiqi SH; Kandala S; Hacker CD; Trapp NT; Leuthardt EC; Carter AR; Brody DL
    Sci Rep; 2023 Mar; 13(1):4052. PubMed ID: 36906616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Individualized Connectome-Targeted Transcranial Magnetic Stimulation for Neuropsychiatric Sequelae of Repetitive Traumatic Brain Injury in a Retired NFL Player.
    Siddiqi SH; Trapp NT; Shahim P; Hacker CD; Laumann TO; Kandala S; Carter AR; Brody DL
    J Neuropsychiatry Clin Neurosci; 2019; 31(3):254-263. PubMed ID: 30945588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in brain connectivity during a sham-controlled, transcranial magnetic stimulation trial for depression.
    Taylor SF; Ho SS; Abagis T; Angstadt M; Maixner DF; Welsh RC; Hernandez-Garcia L
    J Affect Disord; 2018 May; 232():143-151. PubMed ID: 29494898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional connectivity of the anterior cingulate cortex predicts treatment outcome for rTMS in treatment-resistant depression at 3-month follow-up.
    Ge R; Downar J; Blumberger DM; Daskalakis ZJ; Vila-Rodriguez F
    Brain Stimul; 2020; 13(1):206-214. PubMed ID: 31668646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subgenual Anterior Cingulate-Medial Orbitofrontal Functional Connectivity in Medication-Resistant Major Depression: A Neurobiological Marker for Accelerated Intermittent Theta Burst Stimulation Treatment?
    Baeken C; Duprat R; Wu GR; De Raedt R; van Heeringen K
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2017 Oct; 2(7):556-565. PubMed ID: 29560909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accelerated HF-rTMS in treatment-resistant unipolar depression: Insights from subgenual anterior cingulate functional connectivity.
    Baeken C; Marinazzo D; Wu GR; Van Schuerbeek P; De Mey J; Marchetti I; Vanderhasselt MA; Remue J; Luypaert R; De Raedt R
    World J Biol Psychiatry; 2014 May; 15(4):286-97. PubMed ID: 24447053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EEG synchronized left prefrontal transcranial magnetic stimulation (TMS) for treatment resistant depression is feasible and produces an entrainment dependent clinical response: A randomized controlled double blind clinical trial.
    George MS; Huffman S; Doose J; Sun X; Dancy M; Faller J; Li X; Yuan H; Goldman RI; Sajda P; Brown TR
    Brain Stimul; 2023; 16(6):1753-1763. PubMed ID: 38043646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pilot Study of Accelerated Low-Frequency Right-Sided Transcranial Magnetic Stimulation for Treatment-Resistant Depression.
    Tor PC; Gálvez V; Goldstein J; George D; Loo CK
    J ECT; 2016 Sep; 32(3):180-2. PubMed ID: 26909825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stanford Accelerated Intelligent Neuromodulation Therapy for Treatment-Resistant Depression.
    Cole EJ; Stimpson KH; Bentzley BS; Gulser M; Cherian K; Tischler C; Nejad R; Pankow H; Choi E; Aaron H; Espil FM; Pannu J; Xiao X; Duvio D; Solvason HB; Hawkins J; Guerra A; Jo B; Raj KS; Phillips AL; Barmak F; Bishop JH; Coetzee JP; DeBattista C; Keller J; Schatzberg AF; Sudheimer KD; Williams NR
    Am J Psychiatry; 2020 Aug; 177(8):716-726. PubMed ID: 32252538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of prefrontal target region on the efficacy of repetitive transcranial magnetic stimulation in patients with medication-resistant depression: a [(18)F]-fluorodeoxyglucose PET and MRI study.
    Paillère Martinot ML; Galinowski A; Ringuenet D; Gallarda T; Lefaucheur JP; Bellivier F; Picq C; Bruguière P; Mangin JF; Rivière D; Willer JC; Falissard B; Leboyer M; Olié JP; Artiges E; Martinot JL
    Int J Neuropsychopharmacol; 2010 Feb; 13(1):45-59. PubMed ID: 19267956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of intermittent Theta Burst Stimulation (iTBS) and 10-Hz high-frequency repetitive transcranial magnetic stimulation (rTMS) in treatment-resistant unipolar depression: study protocol for a randomised controlled trial.
    Bulteau S; Sébille V; Fayet G; Thomas-Ollivier V; Deschamps T; Bonnin-Rivalland A; Laforgue E; Pichot A; Valrivière P; Auffray-Calvier E; Fortin J; Péréon Y; Vanelle JM; Sauvaget A
    Trials; 2017 Jan; 18(1):17. PubMed ID: 28086851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Impact of Accelerated HF-rTMS on the Subgenual Anterior Cingulate Cortex in Refractory Unipolar Major Depression: Insights From 18FDG PET Brain Imaging.
    Baeken C; Marinazzo D; Everaert H; Wu GR; Van Hove C; Audenaert K; Goethals I; De Vos F; Peremans K; De Raedt R
    Brain Stimul; 2015; 8(4):808-15. PubMed ID: 25744500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective Validation That Subgenual Connectivity Predicts Antidepressant Efficacy of Transcranial Magnetic Stimulation Sites.
    Weigand A; Horn A; Caballero R; Cooke D; Stern AP; Taylor SF; Press D; Pascual-Leone A; Fox MD
    Biol Psychiatry; 2018 Jul; 84(1):28-37. PubMed ID: 29274805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dorsomedial prefrontal cortex repetitive transcranial magnetic stimulation for treatment-refractory major depressive disorder: A three-arm, blinded, randomized controlled trial.
    Dunlop K; Sheen J; Schulze L; Fettes P; Mansouri F; Feffer K; Blumberger DM; Daskalakis ZJ; Kennedy SH; Giacobbe P; Woodside B; Downar J
    Brain Stimul; 2020; 13(2):337-340. PubMed ID: 31711880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Precision targeting in prediction for rTMS clinical outcome in depression: what about sgACC lateralization, metabolic connectivity, and the potential role of the cerebellum?
    Wu GR; Baeken C
    Eur Arch Psychiatry Clin Neurosci; 2023 Oct; 273(7):1443-1450. PubMed ID: 37329365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baseline effective connectivity predicts response to repetitive transcranial magnetic stimulation in patients with treatment-resistant depression.
    Iwabuchi SJ; Auer DP; Lankappa ST; Palaniyappan L
    Eur Neuropsychopharmacol; 2019 May; 29(5):681-690. PubMed ID: 30827757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Pilot Investigation of Repetitive Transcranial Magnetic Stimulation for Post-Traumatic Brain Injury Depression: Safety, Tolerability, and Efficacy.
    Hoy KE; McQueen S; Elliot D; Herring SE; Maller JJ; Fitzgerald PB
    J Neurotrauma; 2019 Jul; 36(13):2092-2098. PubMed ID: 30712461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-Frequency Right Repetitive Transcranial Magnetic Stimulation for the Treatment of Depression After Traumatic Brain Injury: A Randomized Sham-Controlled Pilot Study.
    Rao V; Bechtold K; McCann U; Roy D; Peters M; Vaishnavi S; Yousem D; Mori S; Yan H; Leoutsakos J; Tibbs M; Reti I
    J Neuropsychiatry Clin Neurosci; 2019; 31(4):306-318. PubMed ID: 31018810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Health-related quality of life assessment in depression after low-frequency transcranial magnetic stimulation].
    Dumas R; Boyer L; Richieri R; Guedj E; Auquier P; Lançon C
    Encephale; 2014 Feb; 40(1):74-80. PubMed ID: 24091070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.